[177Lu-DOTA]0-D-Phe1-Tyr3-Octreotide (177Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study
Material type:
TextPublication details: Theranostics; 2016Description: 6:4Subject(s): Online resources:
| Item type | Current library | Status | |
|---|---|---|---|
|
|
College Library | Available |
There are no comments on this title.
Log in to your account to post a comment.